Skip to main content

Table 4 Comparison of anthropometric and biochemical measurements in the dysglycemic patient group and the control group

From: Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus

 

Dysglycemic/obese (n = 6 ) (X ± SD)

Dysglycemic/ offspring (n = 5) (X ± SD)

Control (n = 19) (X ± SD)

Age

53.0 ± 7.66*

46.6 ± 12.0*

24.3 ± 3.7

BMI

33.2 ± 8.28*

33.8 ± 6.7*

22.8 ± 1.4

Waist cm

99.9 ± 14.7*

109.0 ± 20.9*

70 ± 7.7

Hip cm

107.2 ± 8.7*

116.2 ± 24.5

95 ± 7.7

% Lean mass

66.8 ± 7.9

62.8 ± 15.1

74.3 ± 9.9

Total weight

87.2 ± 21.8*

95.8 ± 26.0*

63.1 ± 9.2

Glucose O´

97.2 ± 16.5

100.6 ± 8.8*

83.9 ± 12.5

Glucose 30´

169.7 ± 35.3*

177 ± 39.91

131 ± 30.9

Glucose 60´

182.8 ± 55.0*

196.2 ± 23.8*

113.9 ± 25.3

Glucose 90´

171.0 ± 42.8*

198.0 ± 38.5*

109.27 ± 33.33

Glucose 120´

150.0 ± 45.9*

165.0 ± 20.92*

94.9 ± 21.7

Insulin 0´

16.0 ± 9.6

12.6 ± 5.6

7.3 ± 2.0

Insulin 30´

87.4 ± 42.6

98.7 ± 54.3

56.7 ± 24.6

Insulin 60´

153.2 ± 135.6

126.2 ± 56.4*

57.9 ± 36.2

Insulin 90´

130.3 ± 77.3

131.7 ± 59.0*

54.8 ± 35.8

Insulin 120´

132.2 ± 84.1*

109.1 ± 46.0*

41.4 ± 37.0

Matsuda index

2.9 ± 2.1*

2.4 ± 1.0*

6.2 ± 1.8

HOMA IR

3.5 ± 1.5*

3.2 ± 1.5

1.5 ± 0.4

Free fatty acids

0.5 ± 0.3

0.7 ± 0.2

0.5 ± 0.3

Uric Acid

6.4 ± 1.4

7.12 ± 0.6*

5.2 ± 1.0

Serum Creatinine

0.9 ± 0.3

0.9 ± 0.2

0.8 ± 0.15

Cholesterol

234.5 ± 22.7*

180.8 ± 21.5

200.6 ± 39.6

AST

16.5 ± 7.6

18.2 ± 10.8

10.4 ± 2.0

ALT

12.0 ± 3.2*

19.4 ± 9.9

8.2 ± 2.6

Triacylglycerol

204.8 ± 80.0*

283.6 ± 177.3

110.6 ± 71.2

C4

0.18 ± 0.08

0.25 ± 0.13

0.18 ± 0.08

C2

8.4 ± 1.6

9.8 ± 1.05

8.7 ± 1.6

C16

0.74 ± 0.17

0.85 ± 0.14*

0.67 ± 0.17

C 14:2

0.03 ± 0.02*

0.05 ± 0.03

0.06 ± 0.3

  1. *P value: <0.05.
  2. NOTE: Parameters in bold were significant.